When a physician receives a laboratory result and acts on it, prescribing an antibiotic, adjusting an anticoagulant dose, or initiating a chemotherapy regimen, she is placing clinical trust not just in a number but in a system. Behind every reportable result is a chain of processes: specimen collection, transport, analysis, interpretation, and communication. The reliability of that chain depends on whether the laboratory operating it meets defined, verifiable standards of quality and competence. That is precisely the purpose of ISO standards for clinical laboratories: to establish a rigorous, internationally recognized framework within which laboratories can demonstrate, through independent assessment, that every step of that chain is controlled, documented, and continuously improved.
The International Organization for Standardization (ISO) has published a suite of standards specifically applicable to clinical laboratory medicine. These are not generic quality management documents. They address the unique characteristics of medical testing: the direct connection between laboratory results and patient safety, the complexity of pre-analytical and post-analytical processes that extend well beyond the laboratory’s physical walls, the need for result traceability across institutions and national borders, and the ethical obligations that attach to handling patient-derived specimens and data. Understanding these standards, what they require, how they differ from one another, and what their adoption means in practice, is increasingly relevant for laboratory professionals, healthcare administrators, and any clinician who depends on diagnostic results to guide care.
The ISO Standards Landscape for Clinical Laboratories
ISO is a non-governmental international body with membership drawn from national standardization organizations in over 160 countries. Its Technical Committee 212 (ISO/TC 212) is the working group responsible for standards governing clinical laboratory testing and in vitro diagnostic test systems. The output of TC 212 includes several documents that collectively define what a well-run medical laboratory looks like from a quality and safety perspective.
The central and most widely recognized standard in this family is ISO 15189, titled “Medical Laboratories: Requirements for Quality and Competence.” First published in 2003 and now in its fourth edition following the December 2022 revision, ISO 15189 is the document to which laboratories seek accreditation and against which their competence is formally assessed. But it does not stand alone. ISO 15189:2022 explicitly references and aligns with several companion standards, each governing a specific dimension of laboratory operations.
ISO 22367, “Application of Risk Management to Medical Laboratories,” addresses the systematic identification, assessment, and control of risks across the total testing process. The 2022 edition of ISO 15189 references it extensively, embedding risk-based thinking throughout its requirements rather than treating risk management as a discrete add-on activity.
ISO 20658:2023 governs “Requirements for the Collection and Transport of Samples for Medical Laboratory Examinations.” This standard addresses the pre-analytical phase, which, as multiple published studies confirm, is responsible for 46 to 68 percent of all errors in the total testing process. By establishing requirements for patient preparation, sample collection technique, container selection, labeling, transport conditions, and stability limits, ISO 20658 provides the pre-analytical framework that ISO 15189 references when specifying examination process requirements.
ISO 15190 covers laboratory safety, addressing the biological, chemical, and physical hazards present in clinical laboratory environments. ISO 15189:2022 aligns its safety requirements with ISO 15190’s principles, ensuring that laboratories demonstrate competence not only in analytical quality but in the protection of their workforce.
Historically, ISO 22870:2016 governed point-of-care testing (POCT) separately. The 2022 revision of ISO 15189 incorporated the substance of ISO 22870 directly into the main standard, including it as Annex A. ISO 22870:2016 was subsequently withdrawn, meaning that POCT programs formerly accredited under the combined ISO 15189:2012 and ISO 22870:2016 framework must now demonstrate compliance with the integrated requirements of ISO 15189:2022 alone.
ISO 15189:2022: Structure, Core Requirements, and What Changed
ISO 15189:2022 is the document that defines what a medical laboratory must do and be able to demonstrate in order to be considered competent. Its structure was revised in the 2022 edition to align with ISO/IEC 17025:2017, the standard for testing and calibration laboratories, placing management requirements at the end of the document rather than weaving them throughout. This reorganization is more than cosmetic. It reflects a decision to foreground technical requirements, which are the operational core of what a laboratory does, and position management system requirements as the governance framework that enables and sustains them.
The technical requirements in ISO 15189:2022 span the entire examination cycle. For the pre-examination phase, the standard requires documented procedures for request form design, patient preparation instructions, sample collection and transport, sample receipt and handling, and defined criteria for sample acceptance and rejection. It requires that laboratories communicate their collection requirements clearly to clinical staff and that any pre-analytical deviations be documented with an assessment of their potential impact on result validity.
For the examination phase, ISO 15189 requires that laboratories verify and validate the examination procedures they use before implementation in patient testing, establish internal quality control programs that detect systematic errors and monitor method performance over time, and participate in external quality assessment (EQA) programs that provide comparative proficiency data against peer laboratories. Measurement uncertainty must be evaluated and documented for relevant examination procedures, and all results must be traceable to recognized reference materials or methods where they exist.
The post-examination requirements address result validation before release, turnaround time monitoring, critical value notification procedures, report content and formatting, and the handling of amended or corrected reports. ISO 15189 requires that amended reports clearly identify what was changed and retain the original result in the laboratory record.
The 2022 revision introduced fifteen new terms and definitions, including measurement uncertainty, bias, commutability, impartiality, and laboratory user. This terminological expansion reflects a more precise and internationally harmonized vocabulary that improves consistency across accreditation assessments conducted in different countries. It also introduced a significantly stronger emphasis on impartiality, requiring laboratories to document and actively manage any conditions that could bias their operations or results, particularly where commercial relationships or external pressures might influence reporting.
The expanded risk management requirements, aligned with ISO 22367, represent one of the most substantive changes in the 2022 edition. Rather than treating risk management as a quality tool to be applied selectively, the new standard embeds risk-based thinking throughout the quality management system. Laboratories must identify risks and opportunities at each stage of the examination process, implement proportionate controls, and monitor whether those controls are effective. Management review must now be demonstrably linked to risk assessment outputs and operational quality indicators, closing the gap between governance activity and frontline laboratory operations that earlier versions of the standard often left open.
ISO 15189 and ISO 17025: Why the Distinction Matters
Because ISO 15189 was derived from ISO/IEC 17025, the two standards share structural DNA, and laboratories sometimes encounter the question of whether one can substitute for the other. The answer is no, and the distinction is meaningful.
ISO/IEC 17025 applies to testing and calibration laboratories across all industries, from environmental monitoring to manufacturing quality control to forensic analysis. Its focus is on technical competence and measurement traceability: ensuring that test results are accurate, repeatable, and linked to recognized measurement standards. It does not address pre-analytical processes involving patients, post-analytical clinical interpretation, the ethical dimensions of handling patient data, or the specific patient safety obligations that attach to diagnostic testing.
ISO 15189 was purpose-built to address these gaps. It includes requirements for patient preparation and interaction, sample collection and consent considerations, consultation between laboratory professionals and clinical staff, result interpretation in a clinical context, and the communication of critical values to treating clinicians within defined timeframes. It treats the laboratory as a participant in patient care rather than as a standalone measurement facility. European Accreditation has recommended that medical laboratories transition from ISO 17025 to ISO 15189 precisely because of these clinical-context requirements that 17025 does not cover. Similarly, ISO 17020, previously used in some pathology settings, is increasingly giving way to ISO 15189 as the preferred accreditation framework for medical laboratory work.
The US regulatory landscape adds a further layer. ISO 15189 accreditation is not recognized by the Food and Drug Administration as equivalent to CLIA certification, which means that US laboratories operating under CLIA must meet both frameworks independently if they seek international recognition for their results. This dual compliance reality is particularly relevant for laboratories participating in multinational clinical trials or providing services for globally mobile patient populations.
Global Adoption: Where ISO 15189 Accreditation Stands
According to International Laboratory Accreditation Cooperation (ILAC) 2024 figures, approximately 12,000 laboratories worldwide have been accredited to ISO 15189 through 86 accreditation bodies. Through ILAC’s multilateral mutual recognition arrangements, certificates and test reports from these accredited laboratories are accepted in over 80 countries, enabling results generated in one jurisdiction to be used for clinical decision-making, clinical trial submissions, or public health reporting in another without the need for re-testing.
In the Asia-Pacific region, a Roche Diagnostics benchmarking survey published in the Indian Journal of Clinical Biochemistry found that the proportion of laboratories holding ISO 15189 accreditation increased substantially from 31.9 percent in 2019 to 42.3 percent in 2022. The proportion of laboratories reporting no plans for ISO 15189 adoption decreased from 36.6 to 31.1 percent over the same period, indicating a measurable shift in institutional intent even among those not yet accredited.
The picture in sub-Saharan Africa tells a more complex story that reflects both the importance of the standard and the structural challenges of implementing it. Until 2010, an estimated 380 laboratories across the entire African continent met international standards for quality, and 39 African countries, including Tanzania, had no clinical laboratories meeting minimum international quality requirements. The response to this gap has been substantial. WHO’s Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) and the Strengthening Laboratory Management Toward Accreditation (SLMTA) programs, along with support from PEPFAR and the African Society for Laboratory Medicine, have used ISO 15189 as the reference standard for laboratory quality improvement across the region. As of 2021, Uganda had achieved ISO 15189:2012 accreditation for 23 public laboratories, with more in process. South Africa, Kenya, Nigeria, Ethiopia, and Ghana have all established national laboratory accreditation systems using ISO 15189 as the benchmark. The correlation between this quality improvement trajectory and public health outcomes has been documented: ISO 15189-aligned laboratory improvements have been associated with better HIV treatment outcomes, improved tuberculosis case detection rates, and enhanced epidemic preparedness.
The Accreditation Process: What Laboratories Actually Undergo
Accreditation to ISO 15189 is not self-certification. It requires independent assessment by a recognized accreditation body, which in turn must itself be a member of ILAC’s mutual recognition arrangement to ensure its assessments carry international weight.
The accreditation process begins with an application and preliminary review of the laboratory’s quality management documentation. The accreditation body then conducts an on-site assessment during which qualified technical assessors examine actual laboratory operations against the standard’s requirements. This includes reviewing procedures and records for pre-analytical processes, observing analytical work, evaluating internal quality control data and EQA performance, assessing personnel competency records and training documentation, inspecting equipment calibration and maintenance records, and reviewing corrective action and nonconformity management processes.
ILAC established a three-year transition period from the publication of ISO 15189:2022 in December 2022, ending in December 2025, during which laboratories accredited under the 2012 edition were required to demonstrate compliance with the 2022 requirements. Accreditation bodies, including Spain’s ENAC, communicated this deadline formally: from December 6, 2025, all effective clinical laboratory accreditations must reference the new version. This transition deadline meant that 2024 and 2025 were active years for laboratories globally, particularly those needing to strengthen their POCT governance, risk management documentation, and measurement uncertainty policies to meet the revised requirements.
Once accredited, laboratories are subject to regular surveillance assessments, typically annual or biennial, and must maintain nonconformity registers and corrective action records that demonstrate ongoing compliance rather than compliance achieved only at the point of assessment. Accreditation is designed to be, as UKAS and other bodies emphasize, a commitment to continual improvement rather than a credential earned once and retained indefinitely.
Why Accreditation Translates to Real Patient and System Benefits
The value of ISO 15189 accreditation extends well beyond the certificate issued at the end of an assessment cycle. The process of working toward and maintaining accreditation produces measurable operational benefits that directly affect diagnostic quality and patient outcomes.
One documented example from ISO Library describes a laboratory that, after 18 months of working toward ISO 15189 compliance, saw proficiency testing scores improve to 85 percent acceptable, quality control compliance reach 95 percent, and turnaround times decrease from multi-day intervals to two to three days. These are not incidental improvements. They represent faster, more reliable diagnostic information reaching clinicians at the point of care.
At the system level, ISO 15189 accreditation provides the interoperability foundation that modern healthcare increasingly requires. As clinical trial networks become global, as telemedicine connects patients with specialists across national borders, and as public health surveillance depends on comparable data from laboratories in multiple countries, the ability to rely on results from laboratories that have been assessed against a common standard becomes operationally essential. Laboratories accredited under ILAC mutual recognition do not require the results they generate to be repeated simply because they cross a border. That efficiency has direct patient safety and cost implications.
For laboratory professionals, the standards also provide something less tangible but equally important: a recognized framework for professional accountability. When laboratory scientists demonstrate that their work meets ISO 15189 requirements, they are asserting that laboratory medicine is a discipline with definable, auditable standards of practice, not a technical service that operates at the margins of clinical accountability. That assertion matters for the profession’s standing in healthcare systems, for workforce recognition, and for the long-term investment in laboratory infrastructure that health equity requires.
Conclusion
ISO standards for clinical laboratories, anchored by ISO 15189:2022 and supported by companion standards covering risk management, sample collection, and laboratory safety, provide the internationally recognized framework within which medical laboratories demonstrate quality and competence. With approximately 12,000 laboratories accredited worldwide through 86 accreditation bodies, and with results accepted in over 80 countries under ILAC mutual recognition, ISO 15189 has become the global reference point for what trustworthy diagnostic testing looks like.
The 2022 revision deepened the standard’s requirements for risk management, point-of-care testing governance, measurement uncertainty, and impartiality, reflecting the increasing complexity of modern laboratory operations and the expanding settings in which diagnostic testing occurs. For laboratories still building toward accreditation, particularly in resource-limited healthcare systems, the path is challenging but well-mapped, and the public health benefits of achieving it are documented across multiple global health contexts.
Laboratory medicine influences an estimated 60 to 70 percent of all clinical decisions. The standards that govern how that medicine is practiced are not administrative formalities. They are the structural foundation on which diagnostic trustworthiness rests.
Bio-Reach is a non-profit organization dedicated to advancing Laboratory Medicine through advocacy, education, and global collaboration. To learn more or get involved, visit bio-reach.org.
